Economic evaluation within a factorial-design randomised controlled trial of exercise, manual therapy, or both interventions for osteoarthritis of the hip or knee: study protocol

被引:5
作者
Pinto, Daniel [1 ,2 ]
Robertson, M. Clare [3 ]
Hansen, Paul [4 ]
Abbott, J. Haxby [5 ]
机构
[1] Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, Dunedin, New Zealand
[2] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA
[3] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand
[4] Univ Otago, Dept Econ, Dunedin, New Zealand
[5] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Dunedin, New Zealand
来源
BMJ OPEN | 2011年 / 1卷 / 01期
关键词
COST-EFFECTIVENESS ANALYSIS; PHYSICAL-THERAPY; CLINICAL-TRIALS; TASK-FORCE; HEALTH; RECOMMENDATIONS; MANAGEMENT; CARE; ARTHROPLASTY; STRATEGIES;
D O I
10.1136/bmjopen-2011-000136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Clinical guidelines for the treatment of hip and knee osteoarthritis recommend non-pharmacological and non-surgical treatments. Exercise treatments are recommended as primary strategies, but specific exercise programme components have not been specified. Early evidence indicates that manual physiotherapy is effective for hip and knee osteoarthritis. The Management of Osteoarthritis (MOA) Trial was designed to evaluate the effectiveness and cost-effectiveness of physiotherapist-led, individualised exercise, manual physiotherapy and a combination of these two interventions in the treatment of adults with hip or knee osteoarthrits. This paper describes the methods that will be used to conduct the economic evaluation of these interventions within the MOA Trial. Methods and analysis: This comprehensive economic evaluation will assess the incremental cost-effectiveness of physiotherapy plus usual care versus usual care alone from a societal perspective. The authors will conduct a cost-consequences analysis using end-points such as Outcomes Measures in Rheumatology Clinical Trials-Osteoarthritis Research Society International responder criteria and quality-adjusted life years. The evaluation will have a time horizon of 1 year (and so discounting will not be necessary). All costs will be reported in 2009 New Zealand dollars. The authors will address uncertainty via bootstrapping to calculate CIs for the mean incremental cost-effectiveness ratios and by performing sensitivity analyses. Ethics and dissemination: Ethical approval was granted by the Lower South Regional Ethics Committee of the New Zealand Ministry of Health (ethics reference: LRS/07/11/044). All participants of the MOA Trial provided written informed consent for the capture of their healthcare costs. We will submit the results of the study for publication irrespective of outcome.
引用
收藏
页数:6
相关论文
共 45 条
  • [1] Exercise therapy, manual therapy, or both, for osteoarthritis of the hip or knee: a factorial randomised controlled trial protocol
    Abbott, J. Haxby
    Robertson, M. Clare
    McKenzie, Joanne E.
    Baxter, G. David
    Theis, Jean-Claude
    Campbell, A. John
    [J]. TRIALS, 2009, 10
  • [2] How to develop strategies for improving musculoskeletal health
    Akesson, Kristina
    Woolf, Anthony D.
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2007, 21 (01): : 5 - 25
  • [3] THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS OF THE HIP
    ALTMAN, R
    ALARCON, G
    APPELROUTH, D
    BLOCH, D
    BORENSTEIN, D
    BRANDT, K
    BROWN, C
    COOKE, TD
    DANIEL, W
    FELDMAN, D
    GREENWALD, R
    HOCHBERG, M
    HOWELL, D
    IKE, R
    KAPILA, P
    KAPLAN, D
    KOOPMAN, W
    MARINO, C
    MCDONALD, E
    MCSHANE, DJ
    MEDSGER, T
    MICHEL, B
    MURPHY, WA
    OSIAL, T
    RAMSEYGOLDMAN, R
    ROTHSCHILD, B
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (05): : 505 - 514
  • [4] DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE
    ALTMAN, R
    ASCH, E
    BLOCH, D
    BOLE, G
    BORENSTEIN, D
    BRANDT, K
    CHRISTY, W
    COOKE, TD
    GREENWALD, R
    HOCHBERG, M
    HOWELL, D
    KAPLAN, D
    KOOPMAN, W
    LONGLEY, S
    MANKIN, H
    MCSHANE, DJ
    MEDSGER, T
    MEENAN, R
    MIKKELSEN, W
    MOSKOWITZ, R
    MURPHY, W
    ROTHSCHILD, B
    SEGAL, M
    SOKOLOFF, L
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (08): : 1039 - 1049
  • [5] [Anonymous], 1996, COST EFFECTIVENESS H, DOI DOI 10.1093/OSO/9780195108248.001.0001
  • [6] [Anonymous], 2008, PORTR HLTH KEY RES 2
  • [7] [Anonymous], BURDEN DIS INJURY NZ
  • [8] [Anonymous], OLD NZ 65
  • [9] [Anonymous], 2008, OST CAR MAN OST AD
  • [10] Analysis and interpretation of cost data in randomised controlled trials: review of published studies
    Barber, JA
    Thompson, SG
    [J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7167) : 1195 - 1200